Allogeneic stem cell transplantation for patients harboring T315I BCR-ABL mutated leukemias

類似資料

• The BCR-ABLT315I mutation compromises survival in chronic phase chronic myelogenous leukemia patients resistant to tyrosine kinase inhibitors, in a matched pair analysis
  著者:: Nicolini, Franck E., 等
  出版事項: (2013)
• Epidemiologic study on survival of chronic myeloid leukemia and Ph(+) acute lymphoblastic leukemia patients with BCR-ABL T315I mutation
  著者:: Nicolini, Franck E., 等
  出版事項: (2009)
• Anti-leukemic activity of axitinib against cells harboring the BCR-ABL T315I point mutation
  著者:: Okabe, Seiichi, 等
  出版事項: (2015)
• Major Molecular Response Achievement in CML Patients Can Be Predicted by BCR-ABL1/ABL1 or BCR-ABL1/GUS Ratio at an Earlier Time Point of Follow-Up than Currently Recommended
  著者:: Huet, Sarah, 等
  出版事項: (2014)
• Treatment-Free Remission in Chronic Myeloid Leukemia Harboring Atypical BCR-ABL1 Transcripts
  著者:: Dragani, Matteo, 等
  出版事項: (2020)